Celldex Therapeutics Inc. (CLDX)
NASDAQ · Healthcare
Celldex Therapeutics Inc. Total Liabilities 2020–2025
Celldex Therapeutics Inc. annual total liabilities history from 2020 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Celldex Therapeutics Inc. total liabilities as of December 31, 2025: 55.8M, a 23.12% increase year-over-year.
- Celldex Therapeutics Inc. total liabilities for 2025 were 55.8M, a 23.12% increase from 2024.
- Celldex Therapeutics Inc. total liabilities for 2024 were 45.3M, a 24.36% increase from 2023.
- Celldex Therapeutics Inc. total liabilities for 2023 were 36.5M, a 37.41% increase from 2022.
- Celldex Therapeutics Inc. total liabilities for 2022 were 26.5M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Celldex Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $56 |
| 2024 | $45 |
| 2023 | $36 |
| 2022 | $27 |
| 2021 | $25 |
| 2020 | $26 |
Celldex Therapeutics Inc. Total Liabilities — FAQ
Celldex Therapeutics Inc. (CLDX) total liabilities over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CLDX's total liabilities history?
The chart and table above show Celldex Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.